MedTrace Logo

Validation of Avocatin b as a Biomarker of Food Intake

NCT05009420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-02-09

No results posted yet for this study

Summary

The primary objectives are to

* Identify avocatin b (C17 lipid) in plasma of individuals that consumed 1 avocado.
* Confirm no avocation b present in the plasma of individuals that avoided avocado intake for 7 days.
* Determine the effect of an overnight fast on avocation b detection.

Conditions

  • Healthy

Interventions

OTHER

Avocado

avocado served with crackers as breakfast

Sponsors & Collaborators

  • Hass Avocado Board

    collaborator OTHER

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Britt Burton-Freeman, Ph.D · Illinois Insititute of Technology

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-19
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05009420 on ClinicalTrials.gov